EuroIntervention is a prestigious academic journal dedicated to the field of cardiology and cardiovascular medicine, published by EUROPA EDITION. Established as an essential resource for researchers and healthcare professionals, the journal holds an impressive Q1 ranking in both Cardiology and Cardiovascular Medicine as of 2023, demonstrating its influence and commitment to advancing knowledge in these fields. With an ISSN of 1774-024X and an E-ISSN of 1969-6213, EuroIntervention aims to publish high-quality research and clinical studies that address contemporary challenges in cardiovascular therapies. The journal is recognized for its rigorous peer-review process, ensuring that each article contributes valuable insights to the community. Researchers will find EuroIntervention a vital platform to disseminate their findings and engage with innovative cardiology techniques. Operating from France, the journal aspires to bridge the gap between research and clinical practice, making it an essential read for cardiologists, medical professionals, and students alike, keen to stay abreast of the latest advancements in cardiovascular care.

CORONARY ARTERY DISEASE, published by Lippincott Williams & Wilkins, stands as a vital contributor to the field of cardiology and cardiovascular medicine. Established in 1990, this esteemed journal presents cutting-edge research and insights from internationally recognized experts, facilitating the advancement of knowledge on coronary artery diseases. With its current impact factor placing it in the Q3 category for both Cardiology and Cardiovascular Medicine as well as miscellaneous Medicine, this journal is a valuable resource for researchers, healthcare professionals, and students alike, eager to stay abreast of developments in this critical area of health. Although it does not offer open access, articles published within its pages continue to influence clinical practice and healthcare strategies significantly. Situated at TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103, the journal engages a global audience, maintaining a commitment to showcasing innovative research until at least 2024. Engage with CORONARY ARTERY DISEASE to enhance your understanding and foster progress in cardiovascular health.

Vasa - European Journal of Vascular Medicine is a leading peer-reviewed journal dedicated to advancing the field of vascular medicine, published by HOGREFE AG in Switzerland. With a proud history dating back to 1972, this journal serves as a critical platform for researchers, clinicians, and healthcare professionals committed to enhancing knowledge and practice related to cardiovascular health and vascular disorders. Holding a notable Q2 ranking in the cardiology and cardiovascular medicine category, Vasa’s scholarly contributions reflect high-quality research and innovative insights that drive clinical applications. The journal provides essential access to original articles, reviews, and case studies, fostering a vibrant exchange of ideas within the vascular medicine community. Its Scopus rank of #159 out of 387 further underscores its impact, placing it confidently in the 59th percentile among its peers. Vasa is synonymous with rigorous academic standards and relevance, making it an invaluable resource for anyone seeking to stay at the forefront of vascular research and its clinical implications.

Arquivos Brasileiros de Cardiologia is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. Established in 1950 and published by the ARQUIVOS BRASILEIROS CARDIOLOGIA, this Brazilian journal plays a crucial role in disseminating high-quality research that addresses both emerging and established topics in cardiovascular science. With an impressive history and a commitment to open access since 1997, it provides researchers, healthcare professionals, and students with free and readily available content that significantly contributes to the understanding and management of cardiovascular diseases. The journal is indexed in Scopus and holds a Q3 ranking in the category of Cardiology and Cardiovascular Medicine, demonstrating its relevance and participation within the global research community. Researchers can submit their work and access a wealth of information that spans a variety of subfields, reflecting the journal’s dedication to fostering innovation and collaboration within cardiology. With a mailing address at Avenida Marechal Câmara, 160-330 Centro, Rio de Janeiro, RJ 20,020-907, Brazil, the journal continues to serve as a vital platform for scholarly communication and knowledge exchange in the cardiovascular realm.

Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.

The Journal of Cardiovascular Computed Tomography, published by Elsevier Science Inc, is a premier international journal dedicated to the field of cardiovascular imaging and technology. With a strong impact factor, it serves as a pivotal platform for disseminating cutting-edge research and advancements from 2007 to 2024, specifically within the realms of cardiology and radiology. The journal holds a distinguished Q1 ranking in both Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging, reflecting its influential role in shaping clinical and academic discourse in these fields. Notably, the journal boasts impressive Scopus rankings, placing it in the top decile of its categories, highlighting its high-quality publications and significant contribution to the scientific community. Although it does not operate under an open access model, it ensures robust accessibility for researchers, professionals, and students eager to stay informed about the latest innovations and studies in cardiovascular computed tomography. The Journal of Cardiovascular Computed Tomography is essential for anyone involved in cardiovascular research, offering valuable insights and fostering collaborations across disciplines.

Cardiovascular Intervention and Therapeutics, published by SPRINGER JAPAN KK, stands as a prominent journal within the fields of cardiology and cardiovascular medicine, reflecting its commitment to disseminating groundbreaking research and clinical advances. With an impressive Q2 ranking in Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous), and a Q1 ranking in Radiology, Nuclear Medicine and Imaging, this journal employs rigorous peer-review processes to ensure the quality and relevance of its content. Catering to a diverse audience of researchers, clinicians, and students, the journal aims to foster innovation and enhance understanding through the publication of original research, reviews, and clinical studies focused on cardiovascular interventions and therapies. Spanning over a decade of evolution from 2010 to 2024, Cardiovascular Intervention and Therapeutics continues to be a vital resource for advancing knowledge and practice in the cardiovascular field. Explore the latest advancements and insights that this esteemed journal has to offer, and contribute to the ongoing dialogue that shapes modern cardiovascular medicine.

HEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.

ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, published by Mosby-Elsevier, stands as a leading peer-reviewed journal dedicated to advancing the fields of thoracic and cardiovascular surgery. With an impressive impact factor reflecting its rigorous standards and significance, this journal occupies prestigious Q1 quartiles in 2023 across Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, as well as Surgery. Additionally, it boasts remarkable rankings in the Scopus database, being placed at #8 in Surgery and #29 in Cardiology and Cardiovascular Medicine, underscoring its pivotal role in disseminating high-quality research and clinical insights. Its scope encompasses vital areas such as surgical techniques, innovative therapies, and patient outcomes, making it an essential resource for researchers, clinicians, and students passionate about advancing cardiac and pulmonary health. Though not an open-access journal, it ensures that subscribers and institutional partners can access valuable research contributions published within its pages from 1959 to 2024. The JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY continues to shape the future of surgical practices and enhance patient care on a global scale.